This program is targeted at innovative life science companies that have filed, or will soon file, NDA or 505(b)(2) applications and are anticipating their first Hatch-Waxman litigation. We will focus on pre-suit diligence planning and continuing patent prosecution considerations. Jon Davies, Sanya Sukduang and Jon Cousins will be speaking.
For more information, please email Melissa Monnier.